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Article Information  ABSTRACT 
Received: 19th January 2020  The purpose of the research is to establish a fast, accurate, precise, and low-cost UV-Visible 
spectrophotometry method for the quantitative simultaneous estimation of mefloquine hydrochloride 
and artemether in bulk drug. The UV-Visible method employed was a simultaneous equation method. 
Ethanol was used as a solvent and therefore the absorption maxima (λ max) was found to be 229 nm 
and 209 nm for mefloquine hydrochloride and artemether. The linearity ranges of both drugs were 1-6 
μg/mL and 100 – 350 μg/mL with a regression coefficient r2 ≥ 0.998 respectively. The method was 
validated for different parameters according to International Conference on Harmonization ICH Q2B 
guidelines. The average recovery for mefloquine hydrochloride was found to be 100 per cent and 
artemether 99.3 per cent. The method was also found precise and robust with a per cent relative standard 
deviation of less than 2. All the parameters result obtained within the limits. Therefore, the proposed 
method for the accurate quantitation of mefloquine hydrochloride and artemether in the bulk drug was 
successfully implemented. 
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INTRODUCTION 
Chemically mefloquine hydrochloride is (S)-[2,8-
Bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-
yl]methanol;hydrochloride. It is a potent antimalarial quinoline-
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methanol derivative effective against chloroquine and quinine-
resistant strains of Plasmodium falciparum. It also provided 
suppressive prophylaxis against mosquito-induced infections 
with Plasmodium uiuax and P. falciparum in human [1]. It is 
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practically very soluble in ethanol and insoluble in water. 
Artemether, chemically (1R,4S,5R,8S,9R,10S,12R,13R)-10-
methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1. 
04,13.08,13]hexadecane, is an artemisinin derivative used as an 
antimalarial by Iron-mediated bridge cleavage [2]. Artemether is 
very soluble in dichloromethane & acetone and freely soluble in 
ethyl acetate and insoluble in water. 
 
Several methods for determining mefloquine hydrochloride 
(Fig.1) and artemether (Fig.2) have been published. Some of 
these methods are for the determination by UV-Visible 
spectrophotometer [3 – 6] and RP-HPLC [7 – 9] of mefloquine 
hydrochloride and artemether individually [10] or in 
combination with other drugs. But no single method has been 
reported for mefloquine hydrochloride and artemether 
simultaneous estimation by UV and RP-HPLC. Therefore, an 
effort was made to develop a quick, reliable and cost-effective 
method for simultaneous estimation by UV-Visible 
spectrophotometer of both drugs. 
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Figure 1:  Chemical structure of Mefloquine hydrochloride  
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Figure 2:  Chemical structure of artemether 
 
MATERIAL AND METHODS 
Chemicals and reagents 
The drugs mefloquine hydrochloride and artemether were 
purchased from Sanjay Biological Amritsar, Punjab India. All 
solvents used were of an analytical standard of high quality and 
purchased from Shri Sai laboratory Hoshiarpur, India. Every 
weighing was carried out on a calibrated analytical balance. 
Calibrated glassware’s were used throughout the work. 
 
Instrumentation 
The method was developed by using Lab India 3000+ double 
beam spectrophotometer with a spectral bandwidth of 2 nm. UV-
win software was used to acquire data. The reference and test 
solution absorption spectra were performed over a spectrum of 
200–400 nm.  
 
Solvent Selection 
The solubility of both drugs was checked in different solvents 
and from solubility study, ethanol was found to be a suitable 
solvent. Both drugs were accurately dissolved in this solvent and 
showing no disturbance during recording spectra. 
 
Preparation of Standard Stock Solutions  
Mefloquine hydrochloride and artemether standard stock 
solutions were prepared by correctly measured 100 mg of each 
drug and transferred into the different volumetric flask (100 
mL).  Both were appropriately diluted with ethanol to get a 
concentration of 1000 µg/mL and were kept as stock solutions.  
 
Selection of analytical wavelength 
For the selection of wavelength 4 µg/mL concentration of 
mefloquine hydrochloride and 300 µg/mL of artemether was 
scanned in the wavelength region of 200–400 nm using ethanol 
as blank and the λmax was found to be 229 nm for mefloquine 
hydrochloride and 209 nm for artemether respectively. 
 
A spectrum of mefloquine hydrochloride and artemether 
The overlay spectrum of both drugs has shown in Fig.3. The 
wavelengths 229 nm and 209 nm were selected for mefloquine 
hydrochloride and artemether because at these wavelengths both 
drugs showed maximum absorbance.  
 
Selection of analytical concentration range 
From the standard stock solution of mefloquine hydrochloride 
(100 µg/mL) and artemether (1000 µg/mL), the volume of 0.1, 
0.2, 0.3, 0.4, 0.5, 0.6 mL and 1, 1.5, 2, 2.5, 3, 3.5 mL was 
pipetted out and transferred to different 10 mL of volumetric 
flasks and the volume was made up to 10 mL with ethanol. These 
concentrations were of 1, 2, 3, 4, 5, 6 µg/mL and 100, 150, 200, 
250, 300, 350 µg/mL respectively. Triplicate dilutions were 
prepared separately on each concentration of each drug. The 
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prepared mefloquine hydrochloride and artemether working 
solutions were scanned at 229 nm and 209 nm, respectively. The 
absorbance was recorded for each concentration of both drugs 
and calibration curves were plotted against the concentrations. 
The result of both drugs has shown in table 1- 5 and Fig.4-7.  
The absorptivity coefficients were calculated at both 
wavelengths of each drug. Using equations 1 & 2 the 
concentration of two drugs in the mixture was calculated 
CMFL.HCl = A2 ay1 - A1 ay2/ax2 ay1 - ax1ay2     …………….. 1 
CART = A1 ax2 - A2 ax1/ax2ay1 - ax1ay2           …………….. 2 
Where, A1 and A2 are the absorbances of the mixture at 229 nm 
and 209 nm; ax1 and ax2, absorptivities of mefloquine 
hydrochloride at 229 nm and 209, respectively; ay1 and ay2 
absorptivities of artemether at 229 nm and 209 nm, respectively. 
CMFL. HCl and CART are a concentration of mefloquine 
hydrochloride and artemether in the mixture. The 
multicomponent analysis was carried out by using a 
simultaneous equation method. The % assay was found to be 
98.73 % for mefloquine hydrochloride & 98.93 % for artemether 
respectively. 
 
Fig 3: Overlay Spectra of mefloquine hydrochloride and artemether 
 
Table 1: linear regression analysis of calibration curve (n=6)  
Parameter Mefloquine hydrochloride Artemether 
Working λmax 229 nm 209 nm 209 nm 229 nm 
Beer law limit 1-6 μg/mL 1-6 μg/mL 100-350 μg/mL 100-350 μg/mL 
Regression equation Y=0.0635x+0.0379 Y=0.0915x+0.0681 Y=0.008x-0.0139 Y=0.0004x-0.0171 
Regression Coefficient (r2) 0.999 0.9983 0.9995 0.9994 
LOD  μg/mL 0.207 0.264 9.19 9.36 
LOQ  μg/mL 0.628 0.802 27.8 28.3 
 
Table 2: Results of the linearity curve for Mefloquine hydrochloride at 229 nm.  
Sr. No  Concentration (µg/mL)  Absorbance  
1  1 0.104 
2  2 0.166  
3  3  0.227 
4  4  0.288  
5  5  0.352 
6  6  0.425  
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Figure 4: Calibration Curve of mefloquine hydrochloride at 229 nm 
 
Table 3: Results of the linearity curve for Mefloquine hydrochloride at 209 nm. 
Sr. No  Concentration (µg/mL)  Absorbance  
1  1 0.161 
2  2  0.258  
3  3  0.335 
4  4  0.432  
5  5  0.518 
6  6  0.626  
 
Figure 5: Calibration Curve of mefloquine hydrochloride at 209 nm 
 
Table 4: Results of the linearity curve of Artemether at wavelength 209 nm. 
Sr. No  Concentration (µg/mL)  Absorbance  
1  100 0.068 
2  150 0.108 
3  200 0.145 
4  250 0.186 
5  300 0.230 
6  350 0.269 
y = 0.0635x + 0.0379
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Figure 6: Calibration Curve of artemether at 209 nm 
Table 5: Results of the linearity curve for Artemether at 229 nm. 
Sr. No  Concentration (µg/mL)  Absorbance  
1 100 0.023 
2 150 0.041 
3 200 0.061 
4 250 0.082 
5 300 0.102 
6 350 0.120 
 
Figure 7: Calibration Curve of artemether at 229 nm 
 
VALIDATION OF THE SPECTROPHOTOMETRIC 
METHOD [11] 
Accuracy  
Accuracy was determined by the standard addition method 
calculating the percentage of recovery studies at three 
concentration levels of 80 per cent, 100 per cent, and 120 per 
cent. The mean percentage recovery for mefloquine 
hydrochloride and artemether was found to be 100 & 99.3%. The 
accuracy results have been shown in table 6a & 6b 
 
Precision 
Intraday and interday precision 
For intraday & Interday precision of mefloquine hydrochloride 
and artemether conc. 2.4, 3.0, 3.6 µg/mL and 160, 200, 240 
µg/mL were prepared in three replicates from the stock solution 
and absorbance was taken for both. The absorbance for intraday 
was measured in 2 hours of interval for each set and interday 
result collected in different days. The method was found to be 
precise for intraday and interday with per cent RSD values less 
than 2. The results have been reported in table 7a & 7b. 
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Repeatability 
A minimum of six determinants of 3.6 μg/mL mefloquine 
hydrochloride concentration and 240 μg/mL artemether 
concentration were prepared for repeatability, and absorbance 
was taken for each drug at 229 and 209 nm. The results have 
been reported in table 8a & 8b. 
 
Robustness 
Robustness is a measure of its capacity to remain unaffected by 
small, but deliberate variations in the method parameter. The 
robustness of the method was checked by varying the 
wavelength. There was a change of ± 2 nm. The concentration 
of 2.4 µg/mL for mefloquine hydrochloride and 160 µg/mL for 
artemether was prepared with their three replicates and 
absorbance was measured respectively. From the result data it 
was found that by changing the wavelength ±2 nm, there was no 
change in the original results The results of robustness have been 
reported in table 9a & 9b. 
 
Limit of detection (LOD)  
Limit of detection was calculated from the linearity curve data 
by excel for both drugs and calculation was made using a 
formula. 
𝐿𝐿𝐿𝐿𝐿𝐿 =
3.3 × 𝜎𝜎
𝑆𝑆
 
Limit of quantitation:  
For the limit of quantitation, the data was taken from the linearity 
curve of both drugs and the LOQ was calculated by excels. The 
result of both LOD and LOQ has shown in table 1. 
𝐿𝐿𝐿𝐿𝐿𝐿 =
10 × 𝜎𝜎
𝑆𝑆
 
Where, σ = standard deviation of the response, S = Slope  
The results of LOD and LOQ have been shown in table 1. 
Table 6a: Recovery Study of Mefloquine hydrochloride 
Recovery Sample Fortified sample % Recovery 
Conc.(μg/mL) Absorbance Mean Conc.(μg/mL) Absorbance Mean 
2.4 0.181 0.180 2.4+3.0 0.408 0.410 100 
0.179 0.410 
0.180 0.411 
3.0 0.230 0.229 3.0+3.0 0.459 0.459 100 
0.229 0.458 
0.228 0.460 
3.6 0.263 0.264 3.6+3.0 0.492 0.492 99.6 
0.265 0.490 
0.264 0.493 
Mean of % Drug Recovery 100 
S.D. =Standard Deviation  RSD = Relative standard deviation 
 
Table 6b:  Recovery Study of Artemether  
Recovery Sample Fortified sample % Recovery 
Conc.(μg/mL) Absorbance Mean Conc.(μg/mL) Absorbance Mean 
80 0.058 0.058 80+100 0.129 0.127 100 
0.057 0.127 
0.059 0.126 
100 0.068 0.069 100+100 0.138 0.138 100 
0.070 0.139 
0.069 0.137 
120 0.089 0.089 120+100 0.159 0.157 98 
0.088 0.157 
0.090 0.156 
                 Mean of % Drug Recovery                                                                          99.3 
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Table 7a: Intraday and Interday precision of Mefloquine hydrochloride at 229 nm and 209 nm. 
Parameter Mefloquine hydrochloride (229nm) Mefloquine hydrochloride (209nm) 
Concentration  (μg/mL) 2.4  3.0  3.6  2.4  3.0  3.6  
Precision intraday %RSD 0.571 0.442 0.769 0.746 0.306 0.525 
Interday-1 % RSD 0.555 0.446 0.386 0.366 0.307 0.160 
Interday-2 %RSD 0.546 0.444 0.769 0.362 0.305 0.545 
Interday-3 %RSD 0.847 0.442 0.584 0.740 0.612 0.539 
            
Table 7b:  Intraday and Interday precision of Artemether at 209 nm and 229 nm. 
Parameter Artemether (209nm)                     Artemether  (229nm) 
Concentration  (μg/mL) 160  200  240  160 200  240  
Precision intraday %RSD 0.793 0.672 0.562 1.18 0.984 0.841 
Interday-1 % RSD 0.813 0.649 0.565 1.333 1.02 0.833 
Interday-2 %RSD 0.453 0.963 0.523 1.17 0.968 0.829 
Interday-3 %RSD 0.826 0.680 0.559 1.21 0.984 0.763 
Table 8a: Repeatability of Mefloquine hydrochloride at 229 nm and 209 nm                                 
Sr. No. Absorbance (229 nm) Sr. No. Absorbance (209 nm) 
1 0.258 1 0.375 
2 0.259 2 0.377 
3 0.260 3 0.372 
4 0.261 4 0.371 
5 0.257 5 0.370 
6 0.259 6 0.372 
Mean 0.259 Mean 0.373 
S.D. 0.001 S.D. 0.003 
% RSD 0.386 % RSD 0.804 
Table 8b: Repeatability of Artemether at 209 nm and 229 nm      
Sr. No. Absorbance (209 nm) Sr. No.  Absorbance (229 nm) 
1 0.179 1 0.072 
2 0.180 2 0.071 
3 0.178 3 0.072 
4 0.177 4 0.072 
5 0.180 5 0.071 
6 0.181 6 0.072 
Mean 0.179 Mean 0.072 
S.D. 0.001 S.D. 0.001 
% RSD 0.559 % RSD 0.721 
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Table 9a: Robustness data of Mefloquine hydrochloride 
Mefloquine hydrochloride 229± 2 nm 
(2.4 µg/mL) 
Mefloquine hydrochloride 209± 2 nm  
(2.4 µg/mL) 
Wavelength 227nm 229nm 231nm Wavelength 207nm 209nm 211nm 
Absorbance 
0.195 0.183 0.171 
Absorbance 
0.260 0.278 0.289 
0.193 0.182 0.172 0.262 0.276 0.291 
 0.194 0.181 0.173  0.261 0.277 0.290 
Mean 0.194 0.182 0.172 Mean 0.261 0.277 0.290 
S.D. 0.001 0.001 0.001 S.D. 0.001 0.001 0.001 
% RSD 0.515 0.549 0.581 % RSD 0.385 0.361 0.345 
 
Table 9b: Robustness data of Artemether 
Artemether 209±2 nm (160 µg/mL) Artemether 229 ±2 nm (160 µg/mL) 
Wavelength 207nm 209nm 211nm Wavelength 227nm 229nm 231nm 
Absorbance 
0.132 0.121 0.111 
Absorbance 
0.053 0.046 0.039 
0.133 0.123 0.113 0.054 0.047 0.038 
 0.131 0.122 0.112  0.054 0.046 0.039 
Mean 0.132 0.122 0.112 Mean 0.054 0.046 0.039 
S.D. 0.001 0.001 0.001 S.D. 0.0006 0.0006 0.0006 
% RSD 0.757 0.819 0.893 % RSD 1.11 1.304 1.54 
CONCLUSION  
In conclusion, developed UV-Visible spectrophotometer 
method gave the promising results of validation studies. The 
method’s accuracy was conducted in terms of recovery analysis 
and mean recovery for mefloquine hydrochloride and artemether 
was found to be 100 & 99.3 per cent. The intraday and inter-day 
precision results were found to be less than 2 in terms of a per 
cent relative standard deviation. The proposed Vierordt’s 
method was found to be simple, precise, robust and cost-
efficient. This method can be employed in future for the 
determination of mefloquine hydrochloride and artemether in 
bulk drug. 
 
ACKNOWLEDGEMENTS 
The authors are thankful to the Managing Director of the 
Laureate Institute of Pharmacy, for their support and providing 
lab facility. 
 
FINANCIAL ASSISTANCE  
Nil 
 
CONFLICT OF INTEREST  
The authors declare no conflict of interest. 
AUTHOR CONTRIBUTION 
Amit Choudhary has performed all the experimental work in lab, 
contributed in calculation and wrote the manuscript 
file. Amardeep Ankalgi has contributed in calculation and also 
have checked the manuscript file. Manish Sinha has played a 
role in experimental study. He has checked all the recorded 
parameters during study. He has also checked the final 
manuscript file. Kamya Goyal have checked the final 
manuscript file and also contributed in writing the manuscript 
and final proof reading. Arti Devi have checked the final 
manuscript file and also contributed in writing the manuscript 
and final proof reading 
 
REFERENCES  
[1] Nogueira FHA, Goulart LDPL, César IDC, De Campos 
LMM, Pianetti GA. Development and validation of an 
HPLC method for mefloquine hydrochloride determination 
in tablet dosage form. J. AOAC Int., 94, 1089–93 (2011). 
[2] Goud VM, Deepika S, Gupta A, Sreekanth M, Swamy LK. 
A Review on Analytical methods for the determination of 
Artemether in Pharmaceutical Formulation. Asian J. 
Pharm. Anal., 10, 112 (2020). 
Journal of Applied Pharmaceutical Research 8 (4); 2020: 24 – 32  Choudhary et. al  
 
 
  Journal of Applied Pharmaceutical Research (JOAPR)| October – December 2020 | Volume 8 Issue 4 |   32 
[3] Kalyankar TM, Kakade RB, Attar MS, Kamble AR. 
Simultaneous spectrophotometric estimation of artesunate 
and mefloquine. J. Chem., 2013, 5 (2013). 
[4] Karajgi S. R. TAR and KNV. Simultaneous Determination 
of Artemether and Lumefantrine by Area Under Curve UV 
Spectrophotometric Method. J. Pharm. Sci. Res., 8, 506–11 
(2016). 
[5] Christian J, Shah P, Patel M, Patel K, Gandhi T. Optimizing 
derivatization conditions using an experimental design and 
simultaneous estimation of artemether and lumefantrine by 
ratio first order derivative spectrophotometric method. J. 
Taibah Univ. Sci., 11, 729–40 (2017). 
[6] Arun R, Smith A. Simultaneous HPLC-UV method for the 
estimation of artemether and lumefantrine in tablet dosage 
form. Int. J. Pharm. Biomed. Res., 2, 201–5 (2011). 
[7] Ahmad H, Khandelwal K, Pachauri SD, Gunjan S, Tripathi 
R, Dwivedi AK. HPLC analytical method for simultaneous 
estimation of mefloquine and clarithromycin. J. Biomater. 
Tissue Eng., 4, 567–72 (2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[8] Vinodh M, Vinayak M, Pankaj P, Rahul K, Renita M. 
Analytical method development and validation for 
simultaneous estimation of artemether and lumefantrine in 
pure and pharmaceutical dosage form using RP-HPLC 
method. Malaysian J. Anal. Sci., 17, 348–58 (2013). 
[9] Habib R, Shoaib MH, Ahmed FR, Siddiqui F, Yousuf RI, 
Saleem T, Khan MZ. HPLC-UV method for simultaneous 
quantitation of artemether and lumefantrine in fixed dose 
combination orodispersible tablet formulation. Pak. J. 
Pharm. Sci., 33, 1561–7 (2020). 
[10] Rao A, Murthy R. A rapid spectrophotometric method for 
the determination of mefloquine hydrochloride. J. Pharm. 
Biomed., 27, 959–65 (2002). 
[11]  “ICH Official web site : ICH”.: 
<https://www.ich.org/page/quality-guidelines>, cited 30 
December, 2019. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
